Pancreatic Cancer Research

ResearcherKyorin UniversityNo recent work listed

Naohiko Anzai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0605-0458; OpenAlex author ID A5052777358. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper

Papers 2

  1. c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. Last author DOI 10.3892/or.2012.1878↗
  2. Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318214efce↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keitaro Hayashi · 1 shared paper, 2012 · strength 0.04
  2. Hidemi Goto · 1 shared paper, 2011 · strength 0.03
  3. Nobumasa Mizuno · 1 shared paper, 2011 · strength 0.03
  4. Shigeru B. H. Ko · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.